Abstract
The human gastrointestinal tract is inhabited by a vast population of bacteria, numbering ~100 trillion. These microorganisms have been shown to play a significant role in digestion, metabolism, and the immune system. The aim of this study was to review and discuss how the human body interacts with its gut microbiome and in turn the effects that the microorganisms have on its host, overall resulting in a true mutualistic relationship.
Video abstract
Point your SmartPhone at the code above. If you have a QR code reader the video abstract will appear. Or use:
Introduction
The word “microbiome” was first coined by American Molecular Biologist Dr Joshua Lederberg to imply the environmental and biological community of commensal, symbiotic, and pathogenic microorganisms that share human body space and have been all but ignored as elements of health and disease.Citation1 The microbiome is defined as the overall collection of microbiota that resides inside humans or on their skin surface.Citation2–Citation5 It has been recognized for some time that the human body is colonized by at least ten times more bacteria than the figure of human cells in the body and that most of these bacteria live in the human gastrointestinal (GI) territory.Citation6–Citation8 It has been estimated that ~10–100 trillion commensal bacteria occupy the human GI tract; therefore, the figure that vastly outnumbers the number of cells of human origin.Citation5,Citation8,Citation9 Nevertheless, “the total cell number of a human being ranges between 102 and 10Citation16 and it is widely mentioned without a proper reference.”Citation10 In a recent report, it was found that “the number of cells in the human microbiota is likely to be highly variable depending on nutritional input, body size, age, ethnicity, culture, and environment.”Citation11 Although worldwide most research has concentrated on microorganisms that cause disease and microbial drug resistance, due to unknown reasons, studies on the microbiome and their its benefits in the human body did has not had a similar prioritisation or urgency as those on pathogenic microorganismsin many communities and countries.Citation7,Citation12–Citation19 There are an innumerable variety of microorganisms in nature, many of which can cause diseases in humans. However, the human body is a host to a great number and assortment of bacteria, viruses,Citation20 and fungi,Citation21 which are beneficial to health and well-being. It has been reported that the normal inhabitant bacterial flora of the human body is poorly understood.Citation22–Citation25 Although they are termed commensals, bacteria comprising the gut microbiome share a much stronger relationship with the human host than the term suggests.Citation26–Citation29 Commensalism is a form of symbiosis whereby one organism gains from its association with another organism, whereas the other is affected in neither a positive nor a deleterious manner. There is more of a mutualistic nature to the bond shared by human host and bacterial colonizers in that the relationship benefits both parties: the microbiome is provided with an environment to live in and a readily available source of nutrients, and the human receives metabolites from bacterial digestion which it could not have otherwise obtained.Citation29–Citation31 As the human hostages, the gut microbiome gains a level of stability that suggests a strong interrelationship between host and bacteria, which has evolved over a substantial period.Citation32,Citation33 In addition, in the process of digestion and metabolism, these bacteria play an important role in the immune system and other body functions.Citation34,Citation35 Over the last 20 years, it has been shown that it is possible to modulate the composition and metabolic activities of the gut microbiome such that the health benefits to the host are maximized while reducing the deleterious effects of pathogenic organisms.Citation34,Citation36–Citation39 This has made the study of the microbiome a subject of great interest.
Anatomy of the gut and bacterial compositions
The GI tract starts at the mouth, connects to the esophagus and thence to the stomach and small and large intestines, and ends at the rectum. The GI tract can be visualized as a long tube that passes uninterrupted through the body from lips through to anus. The stomach, small bowel, and colon are the organs that constitute the gut. The large intestine is the most densely populated section of the GI tract. The stomach contains relatively low numbers of bacteria, primarily due to the acidic nature of gastric juice. Stomach contents are also retained for a relatively short time; therefore, the food supply for bacteria is limited. Despite this fact, microbial populations in the stomach can reach 103 organisms per gram of contents, rising to 106/g after a meal, due to the buffering capacity of food.Citation40,Citation41 The predominating microbial species are acid-tolerant lactobacilli and streptococci, which can withstand a low-pH environment to some extent.Citation41 Bacteria are considerably more numerous in the distal small bowel and large intestine. The transit of contents through the colon takes considerably longer time, which provides time for complex microbial communities to develop.Citation42 Currently, the microbe population living in the human intestine is named “gut microbiota” (previously known as “gut flora”).Citation43 Human gut microbiota comprises tens of trillions of microorganisms, counting at least 1,000 different species of known bacteria with more than three million genes (150 times more than human genes).Citation43,Citation44 The most abundant species belong to the phyla Bacteroidetes and Firmicutes, which account for up to 90% of all the bacteria in the distal gut.Citation45 Human intestine accommodates multifarious-community microbial cells that have an impact on humanoid “physiology, metabolism, nutrition and immune function while disruption to the gut microbiota has been linked with GI conditions such as inflammatory bowel disease (IBD) and obesity.”Citation37
Digestion in the human gut
It was traditionally considered that the main function of the large intestine was principally the reclamation of water and salts and that it had little or no role in digestive processes, which occurred in the stomach and small intestine. However, it has been shown that a small, but significant contribution is made to digestive processes by the large gut, as modulated by the microbiome.
Carbohydrate digestion
Carbohydrate catabolism (and, to a lesser extent, protein breakdown) yields short-chain fatty acids (SCFAs), and this is done by a process called fermentation, which is conducted by anaerobic bacteria in the gut.Citation46 Carbohydrates that can be grouped under the term “dietary fibers” are the most common sources of SCFAs, as well as starches that are not digested in the small intestine.Citation47,Citation48 Dietary fibers are indigestible in humans; therefore, the fermenting actions of the gut microbiota generate SCFAs for human use. The three principal SCFAs found in the human body are butyrate, propionate, and acetate, in an approximate ratio of 1:1:3.Citation49 Approximately 95%–99% (the clear majority) of SCFAs produced in the gut are absorbed.Citation50 SCFAs, predominantly butyrate, are vital sources of energy for colonocytes, and up to 70% of their energy needs may be gained through fermentation.Citation41 It has been shown in mice that a lack of a microbiome, and therefore no production of butyrate, can lead to autophagy (self-digestion of cells in response to an energy and nutrient deficit) of the colon cells.Citation9,Citation51,Citation52 The colonocytes of these germ-free mice were also found to be energy-deficient, as well as having reduced levels of enzymes that catalyze reactions such as those in the citric acid cycle.Citation51 This highlights the importance of a microbiome and the substantial contribution they make to energy supply. The SCFAs are useful energy sources as well as playing a role in the human immune system. A recent study detected that SCFAs also regulate the immune system and inflammatory response.Citation52 They diminish the sensitivity of lamina propria macrophages to commensal bacteria, via nitric oxide, IL-6, and IL-12 independent of free fatty acid receptor signaling, to persuade tolerance.Citation53 The SCFAs, especially propionate and butyrate, have also been shown to inhibit the expression of lipopolysaccharide-induced cytokines, IL-6 and IL-12p40, in human mature dendritic cells.Citation54 The SCFAs, which were used therapeutically in inflammatory diseases in a controlled experimental setup, showed improvements in IBD and acute radiation proctitis, as it plays a direct anti-inflammatory role.Citation55–Citation57 Propionate and acetate have been found to show an anti-inflammatory action on human monocytes by regulating cytokine and chemokine production, such as IL-10 and MCP-1.Citation58 MCP-1 is one of the key chemokines that regulate migration and infiltration of monocytes/macrophages.Citation59 Propionate and butyrate have also exhibited anticancer properties.Citation60,Citation61
Protein digestion
The breakdown of protein by the gut microbiota also contributes to SCFA production, but not as profoundly as carbohydrate fermentation. However, this process releases a greater variety of end products such as hydrogen, carbon dioxide, ammonia, thiols, amines, indoles, and phenols. Many of these substances are considered toxic and have carcinogenic effects. Thus, protein catabolism is a less beneficial process compared with carbohydrate fermentation.Citation41 It can be noted that many large bowel diseases occur in the distal gut (ie, the descending and sigmoid colons). As food passes along the bowel, the most easily digestible material (carbohydrates) will be used up first; therefore, protein digestion becomes more important in the distal sections. Signature products of amino acid breakdown are branched-chain fatty acids (BCFAs), and it was found by the experiments conducted with human sudden death victims that the concentrations of BCFAs were notably higher in gut contents obtained from the distal large bowel than that of the proximal colon. SCFAs, produced during protein digestion, more than doubled from 17% to 38% in the distal large gut. This evidence points to protein breakdown and the production of toxic by-products as potential causes of diseases in the distal large gut.Citation41
Modulation of the microbiome
As it is well established that a healthy gut microbiome has many positive effects on their human hosts and has influence on diseases, thoughts have turned to how to change and enhance the microbiome to gain further health benefits.
Prebiotics
A prebiotic is defined as a nonviable food component that confers a health benefit on the host associated with the modulation of the microbiota.Citation62,Citation63 Although most foodstuff will change the levels of bacteria in the gut,Citation64 nonviable food ingredients such as inulin, fructo-oligosaccharides, and galacto-oligosaccharides have a more specific effect on the growth of beneficial bacteria, such as bifidobacteria and lactobacilli.Citation65 Both are gram-positive anaerobes, which are specialized in the breakdown of carbohydrates in the gut.Citation66 As mentioned above, carbohydrate digestion produces SCFAs, which is beneficial to the gut. A few negative effects of prebiotics have been recorded, such as a slight laxative effect and flatulence from both inulin-derived oligosaccharides and galacto-oligosaccharides; however, this is only the case when significant quantities are consumed, and therefore, overall, the benefit far outweighs any potential drawbacks. To make a prebiotic function effectively, it must be able to pass undigested through the GI tract and to reach its target bacteria in the gut, where it can be fermented. Furthermore, the target bacteria themselves must be present in the gut for there to be any modulatory effect.Citation67 Many common foodstuffs such as onions, garlic, and bananas naturally contain oligosaccharides with prebiotic potential.Citation68 However, it is believed that these polysaccharides are present in a too low concentration to significantly alter the levels of bacteria in the gut. This has led to the initiative of extracting and purifying prebiotics and then fortifying common foodstuffs such as table spreads, drinks, and cereals.Citation68 This has been proven to be a less expensive method of modulating the gut microbiome than using probiotics.Citation64 Prebiotic compounds can be extracted from plant sources. Another technique to produce galacto-oligosaccharides is to break down lactose, an abundant by-product in the manufacture of dairy goods, using β-galactosidases.Citation65 This method consumes substrates that would otherwise have gone to waste as well as can produce the prebiotic.
Probiotics
Probiotics used in humans are live bacteria and yeasts, which are delivered to the gut via oral ingestion.Citation67 They are often ingredients in food products, which have a unique selling point, making them very popular with members of the public, but is there any truth in the usefulness of probiotics? Like prebiotics, to make probiotics effective, they must be resistant to digestion in the upper gut, such that they can reach sections of the bowel where they can seed and grow.Citation67 Probiotics have been shown to confer beneficial effects on the host. They compete with pathogenic microbes for nutrients and space to grow, inhibiting pathogenic growth.Citation69 Furthermore, some probiotics such as bifidobacteria, but mainly lactobacilli, produce peptides called bacteriocins that have antimicrobial properties and are used to kill pathogenic bacteria.Citation70 Although several research reports have confirmed that the consumption of probiotics has numerous health benefits,Citation71–Citation74 nevertheless, “health authorities have only approved claims on (a) lactose intolerance and lactose digestion and (b) cholesterol reduction mostly because of biomarker deficiency.”Citation75 The risk of myocardial infarction is three times higher in those with a high lipid profile than in those with normal levels of blood lipids.Citation76 The cholesterol-reducing ability of probiotics has been extensively studied and has revealed that total plasma cholesterol and low-density lipoprotein cholesterol can be reduced by 7.84% and 9.27%, respectively.Citation77,Citation78 Existing accessible antimicrobial treatments for yeast vaginitis, candidiasis, bacterial vaginosis, and urinary tract infection can often lead to a number adverse drug reactions, such as diarrhea, superinfections, depression, and even renal failure.Citation75 Moreover, antimicrobial resistance inclines to decline the usefulness of this therapy over time.Citation17–Citation19 Lactobacilli have been shown to create biosurfactants and collagen-binding proteins that inhibit pathogen adhesion to the vaginal wall. This actually explains the reason why the vaginal mucosa is conquered by lactobacilli, making access to pathogens problematic.Citation79 Probiotics available in the marketplace for oral health include species of Lactobacillus and Bifidobacterium.Citation80 Several studies have demonstrated that Lactobacillus and Bifidobacterium can decrease the oral levels of the cariogenic species Streptococcus mutans.Citation81–Citation84 Streptococcus salivarius K12 has also been recognized to generate several proteins that are active against closely related strain (bacteriocins) such as Streptococcus pyogenes and Streptococcus pneumonia and avert repeated pharyngitis, otitis media, and tonsillitis.Citation85,Citation86 Microbial β-galactosidase in yogurt is resistant to gastric acid and supports lactose digestion.Citation75 Multiple studies detected that the symptoms of lactose malabsorption improved due to extra production of β-galactosidase by probiotic cultures.Citation87,Citation88 Furthermore, it has been observed that milk containing Lactobacillus acidophilus also aids lactose absorption and shows improvement in lactose-intolerant patients.Citation89 Probiotic supplementation can also modify the quantity of colonic microbiota and improve symptoms in lactose-intolerant subjects.Citation90
Symbiotics
A symbiotic is a combination of a prebiotic and a probiotic.Citation91 There is a sound logic behind the symbiotic concept; the probiotic component will aid in metabolism and host immunity, whereas the prebiotic selectively stimulates the growth of the probiotic, and other beneficial bacteria already extant in the gut. Overall gut health is positively modulated. The effectiveness of symbiotics has been investigated in several diseases. The symbiotic therapy involving Bifidobacterium longum and Synergy 1 has been shown to have benefits to both Crohn’s disease (CD) and ulcerative colitis (UC) patients. B. longum was chosen from a selection of nineteen bifidobacterial strains. This choice was made based on testing for desired characteristics: aerotolerance, acid tolerance, bile salt resistance, adhesion to epithelial cells, and ability to use oligofructose as an energy source, as well as a capacity to withstand freeze-drying and storage. The bacterium that predominated in all categories was B. longum.Citation92 Synergy 1 is made from inulin from the chicory plant and oligofructose.Citation67 Another important bacterium is Faecalibacterium prausnitzii, which is found in ample quantity (5% of the total bacterial population) in the human intestinal microbiota of healthy adults.Citation93 This species is a highly functionally active member of the microbiome, influencing numerous host pathways.Citation94 Several intestinal disorders were noticed to contain low numbers of F. prausnitzii, particularly in IBD patients.Citation93,Citation95 Hence, the number of intestinal F. prausnitzii can be recommended as an indicator of intestinal health.Citation93–Citation95 Immunologic dysregulation is the reason of numerous noninfectious human illnesses. The GI tract is the principal location of contact between the “host immune system and microorganisms, both symbiotic and pathogenic.”Citation96 Intestinal bacteria are considered for the development and function of the immune system. From the clinical, epidemiological, and immunological evidence, it was concluded that the absence of valuable microorganisms that sponsor appropriate immune development leads to the inflammatory responses including IBDs.Citation97
Diet-related dysbiosis, coeliac diseases, gluten-free diet (GFD), breast milk, western diet, and polyphenols
The impact of food on the arrangement of the microbiota has been shown during the preliminary colonization phase: breastfed newborns have advanced levels of Bifidobacteria spp., whereas formula-fed infants have higher levels of Bacteroides spp., as well as amplified Clostridium coccoides and Lactobacillus spp.Citation98 The microbiota was assumed to maintain a relatively steady state all the way through life after the postnatal epoch. Nevertheless, quite a recent study have revealed that dietary influences modify the microbial community, resulting in biological deviations to the host.Citation99 It is extensively documented that the intestinal microbiota plays a role in preventing the commencement and continuation of intestinal inflammation in an ample number of chronic intestinal diseases.Citation100 Several studies reported that Celiac disease (CeD) patients with GI indicators are also recognized to have an altered microbiota.Citation101–Citation104 It has been observed that the numbers of Bifidobacterium spp. and B. longum were significantly reduced, and the numbers of Bacteroides spp. were increased in stools and duodenal biopsies of CeD patients, untreated and treated with a GFD, compared with control subjects.Citation101,Citation102 In addition, specific bacterial strains isolated from patients with active and nonactive CeD have been shown to have augmented virulence features. These outcomes recommended that microbiota modifications are of significance to the inflammatory status characteristics of the vigorous stage of the disease. These alterations could perform both a secondary role by enraging CeD pathogenesis and engendering a vicious circle and a primary role in contributing to disease onset.Citation100 Diet is the most important eco-friendly factor impelling gut microbiota multiplicity and functionality, which might be pertinent to subjects following dietary remedies. The CeD is an enteropathy caused by an atypical immune response to cereal gluten proteins, and the solitary therapy is the obedience to a GFD.Citation105 Human milk is a comprehensive source of sustenance for the newborn.Citation106 Human microbial colonization commences at birth and progresses and modifies in species profusion for ~3 years while waiting for the microbiota to grow into adult form. Toddlers go through noteworthy, evolving ups and downs of microbial colonization that encourage their health status as well as their immune system.Citation107 Exclusive breastfeeding for 6-months encourages the infant’s progress towards the multiplying of a defensive intestinal microbiota. The milk glycans among the many components of milk have been identified as chauffeurs of microbiota development and overall gut health because of its inherent properties of pleiotropic functions, conferring protection against infectious diseases.Citation106 Furthermore, intestinal permeability in preterm infants characterizes a life-threatening balance between the absorption of nutritional agents and protection from dangerous pathogens. Newborns who received either exclusive or a majority of feeding as human milk revealed significantly lower intestinal permeability when compared to infants receiving minimal or no human milk in postnatal days.Citation108 Western diet, which contains highly refined haphazard foods with poor nutritional quality essentially constituting sugar and fat, causes dysbiosis that upsets both host GI tract metabolism and immune homeostasis.Citation109–Citation111 Another study highlighted typical Western diet converts the microbiota composition shifting to an overgrowth of Firmicutes including Clostridium innocuum, Eubacterium dolichum, Catenibacterium mitsuokai, and Enterococcus spp., as well as a significant reduction in several Bacteroides spp.; however, traditional food regimes rich in plant polysaccharides are linked with a Prevotella enterotype.Citation52,Citation112 It also reported that such a typical diet can cause 71% upsurge in plasma levels of endotoxins, proposing that endotoxemia may progress in folks with GI barrier dysfunction associated with dysbiosis.Citation113 Dietary polyphenols extant in a wide-range of vegetables and fruits have been associated with positive health benefits.Citation114,Citation115 It has also been reported that variances in the dispersal of bacteria are linked with dietary habits and this in reality provocates and promotes the host to be exposed to microbial metabolites.Citation115 Another group of scientist revealed that the gut microbiome of children living in remote West African countries was significantly different from that of the children of the same age from the most sophisticated European countries.Citation116 Similar observation of differences in gut microbiome was found between communities, in rural and urban areas, and residents in non-industrialized and industrialized societies.Citation117,Citation118 Multiple studies reported that dietary polyphenols are entrusted to conserve the intestinal health by protecting the gut microbial equilibrium through the encouragement of the development of beneficial bacteria (ie, lactobacilli and bifidobacteria) and the inhibition of pathogenic bacteria, wielding prebiotic-like properties.Citation119–Citation125
Fecal microbiota transplantation (FMT)
FMT (or bacteriotherapy) is the relocation of stool from a healthy giver into the GI tract with the determination of treating recurrent Clostridium difficile colitis.Citation126 C. difficile infection (CDI) is the leading cause of antibiotic-associated diarrhea, and the infection rates are increasing.Citation127–Citation129 CDI treatment choices are restricted and seem to lose efficacy due to resistance. Recurrent disease is particularly puzzling; extended treatment with oral vancomycin (Eli Lilly and Company, Indianapolis, IN, USA) is becoming increasingly common, but is expensive.Citation127 The emergence of the hypervirulent C. difficile strain has been related to a rise in disease severity, with mortality reported in up to 6.9% of cases.Citation130 The associated economic burden is also significant.Citation128 Nosocomial CDI upsurges the cost of treatment by fourfold, translating to a cost reported up to $4.8 billion/year in the USA.Citation131,Citation132 FMT embraces substantial potential as a therapy for recurrent CDI with very minimum cost, but still requires more research.Citation127–Citation129
Microbiome and its relationship to disease
IBD
IBD is a general term used to define many conditions that cause inflammation of the GI tract, with the two main forms being UC and CD. Both are chronic illnesses that are characterized by inflammation, which often goes into remission and then flares up throughout the sufferer’s lifetime. A study conducted in Germany tested the hypothesis of a genetic link in IBD. Monozygotic twins were found to have a tenfold increased risk of developing the condition than dizygotic twins, emphasizing a strong genetic link in sufferers of IBD, especially CD.Citation133 Recent advances have provided substantial insight into genetic relation with IBD. Epidemiological data shows the prevalence among different geographical areas, ethnic groups, familial predisposition, and concordance in twins.Citation134,Citation135 IBD is a peaks-and-valleys disease categorized by diarrhea, abdominal pain, and weight loss.Citation135 Recently, it has been observed that IBD has a strong correlation with sleep, circadian rhythms, and melatonin.Citation136 Sleep disorders have become a global issue; currently, in modern society, lack of sleep, shift work, or circadian misalignment is an extremely common issue. The total sleep time has increasingly declined over the last 25 years as the change of work environment, frequent long flights, and mobility have been internationally altered and posed a challenge to human circadian homeostasis.Citation137,Citation138 Insomnia and other sleep disorders are associated with many serious adverse health miseries, economic consequences, and, furthermost significantly, has amplified all-cause mortality.Citation139 It has been observed that there is a strong correlation between sleep and the immune system. Although the total issue regarding sleep and immunity is complex and poorly understood,Citation139 sleep strengthens immune functionCitation131 and deprivation has been shown to have damaging effects on the immune system and can lead to leukocytosis and an increase in natural killer cells, which can lead to increased inflammatory cytokine production.Citation140–Citation142 Environmental factors were also considered as an indispensable gear of the pathogenesis of IBD and chiefly accountable for its mounting incidence worldwide.Citation143 Many environmental hazardous aspects have been identified “including smoking, appendectomy, oral contraceptives, diet, breastfeeding, infections/vaccinations, antibiotics, and childhood hygiene.”Citation142 None of these environmental factors were isolated as the definite cause of IBDs.Citation143,Citation144 The identification of various alterations of the gut microbiota composition in IBD has enabled using very advanced next-generation sequencing technology.Citation145 Alterations in the ecological system have been reported within the gut, that is, intestinal microbes and the immune system.Citation146,Citation147 “The most consistent observation in IBD is reduced bacterial diversity, a decrease of Firmicutes, and an increase of Proteobacteria.”Citation145 Although many factors such as “host, genetic, and environmental” influences have been identified as for the pathogenesis of IBD,Citation140 currently, only smoking has been identified as the most potential and specific environmental factor for the onset of IBD.Citation148–Citation150
CD
CD is a patchy transmural inflammation in the GI tract, which is found anywhere from the mouth to the rectum. Typically, the most common sites of inflammation are the distal sections of the small intestine such as the ileum and the colon. The severity of the condition can range from no symptoms at all (during times of remission) to acutely life-threatening.Citation151 Epidemiologically, the condition is most prevalent in the developed nations of Europe and the USA, with significantly lower incidence in the Southern Hemisphere.Citation152 Although the pathology and physiology involved in CD are not completely understood, there appear to be many factors that predispose to the condition: bacterial activity in the gut, genetic susceptibility, and irregular immune response.Citation151,Citation152 The inflammatory response found in CD is defined by the release of type 1 helper T-cell cytokines, namely tumor necrosis factor-alpha (TNF-α), interferon gamma (IFN-γ), and IL-12.Citation151 The traditional treatments for CD are steroids, anti-inflammatory drugs, and, in particularly severe cases, surgical resection of inflamed portions of the bowel, with ~70% of sufferers requiring surgical intervention during their lifetime.Citation151 However, there is an increasing interest in alternative therapies involving probiotics, prebiotics, and symbiotics. Probiotics have been extensively tested, with varying results. For example, Lactobacillus GG was found not to reduce the rates of recurrence in the disease, and Nissle 1917, a strain of Escherichia coli, was found to promote quicker remission of the disease, but not to affect the rates of remission between subjects.Citation67 The use of prebiotics, on the other hand, has not been explored as deeply, and the few studies conducted have been little more than pilot studies. Symbiotics have shown more potential than either probiotics or prebiotics in isolation. A double-blind randomized control trial was conducted on 35 patients with CD to ascertain the effectiveness of the symbiotic therapy comprising B. longum and Synergy 1.Citation153 In the present study, appropriately selected subjects ingested either the symbiotic or a placebo every day, for the duration of 6 months. Patients were required to keep a bowel habit diary for the duration of the test. Furthermore, at the beginning, 3 months, and finally 6 months into the study, patients were required to undertake a Crohn’s disease activity index (CDAI) assessment, fill out an IBD lifestyle questionnaire, and undergo flexible sigmoidoscopy or colonoscopy. Biopsies were taken for histological analysis. The study found that there were significant improvements in the CDAI and histological scores of the symbiotic group compared with the placebos. The numbers of B. longum in the gut mucosa were found in higher abundance coupled with larger populations of other bifidobacteria. Another important finding was that after 3 months of therapy, the levels of TNF-α (the principal inflammatory cytokine in CD) were markedly reduced in the symbiotic group. However, the reduction in TNF-α was not as significant at the 6-month check-up. Overall, this study showed that symbiotics have the potential to be a viable treatment for CD, which may become more commonplace with time and development.
Ulcerative colitis
UC is one of the two main forms of IBD and is characterized by the formation of ulcers in the lining of the colon and rectum, with patients usually presenting with diarrhea, and with mucus and blood in their stools.Citation154 It is distinct from CD in terms of site, presentation, and histology. The condition also exhibits more of a type 2 helper T-cell-mediated response, with the production of cytokines such as TNF-α, IL-1α, IL-1β, IL-5, IL-8, and IFN-γ.Citation91 These cytokines recruit neutrophils and monocytes into the mucosa via chemotaxis. As with CD, the etiology is not fully understood, but there is evidence that points to an inappropriate inflammatory response to the gut microbiome. The main classes of drugs used to treat UC are aminosalicylates, corticosteroids, and immunosuppressant, with many patients eventually requiring a colectomy.Citation154 Probiotics such as VSL#3 (a combination of eight different probiotic bacteria) were found to induce remission in 93% of subjects compared with 36% of the placebo group. Furthermore, the rates of relapse were considerably higher (73%) in the placebo group and only 21% to those on the probiotic course. These are quite convincing figures to the effectiveness of VSL#3; however, it is worth noting that this study was conducted on a cohort of children and adolescents, and the efficacy in adults may not necessarily be the same.Citation155 Multiple studies reported that still there is doubt regarding VSL#3 efficacy and thereafter more research is suggested.Citation156–Citation158 As with CD, the combination therapy of B. longum and Synergy 1 has been tested on UC patients. After 4 weeks of therapy, the symbiotic group was found to have improved sigmoidoscopy scores and substantially reduced levels of IL-1α and TNF-α (which are usually elevated in UC patients). A drop in the concentrations of inducible human beta defensins (hBD) was also recorded in the symbiotic group. This is a strong indicator that the inflammation was reduced, as hBD is only produced and released by epithelial tissue when inflamed. It was also noted that the numbers of bifidobacteria in the gut had increased by ~42 times their original number.Citation152 Overall, there was an improvement in bowel activity and positive clinical findings that lay down a foundation for further development of symbiotic treatment.
Irritable bowel syndrome (IBS)
IBS is a chronic illness characterized by the presence of abdominal pain or discomfort, which may be associated with an increased frequency of defecation and/or accompanied by a change in bowel habit as stated in the National Institute for Health and Clinical Excellence Guidelines.Citation159 The etiology of this condition is poorly understood, with possible causes ranging from mal-fermentation of food substrates to psychosocial factors such as stress.Citation160 However, it is noted that almost half of the IBS sufferers can identify a definitive event before their symptoms began, for example, surgery, the use of antibiotic drugs, or a spell of gastritis. These are all known to disturb the gut microbiome; therefore, it is hypothesized that this disruption to the bacteria is key to the pathogenesis of IBS.Citation161 Investigations have shown that the composition of the microbiome in IBS patients differs from the norm with a higher presence of facultatively anaerobic microorganisms such as Streptococcus spp., E. coli, and Proteus spp. Conversely, lactobacilli and bifidobacterial populations were reduced compared with nonsufferers.Citation161 Due to the potential importance of the microbiome in this condition, the idea to modulate it with probiotics and prebiotics presents itself. Many studies have been conducted, but the results are yet being not conclusive, but it shows some promise.
Bacteria in the body over time
Neonates
The gut microbiome, and principally the study of its ancestries in neonates, have become subtopics of great curiosity within the arena of genomics.Citation162 The human body does not develop a microbiome until after birth; the sterile nature of the womb prevents microbial colonization until birth. It has been shown in studies conducted in Finland,Citation163 as well as in India,Citation164 that the method of delivery affects the composition and development of the microbiome. Colonization of mucosa in the digestive, respiratory, urogenital tracts, as well as the skin, begins at, or perhaps even before, the time of birth when a newborn is exposed to a mother’s microbiota.Citation165 Beforehand it was believed that the utero environment was mostly sterile and that a fetus was not colonized with bacteria until the time of birth.Citation165 Babies born by natural means, that is, gain their bacteria from the vaginal tract and fecal matter of the mother, resulting in a more regular and healthy microbiome. The species most commonly found in this community are Acinetobacter spp., Bifidobacterium spp., and Staphylococcus spp. On the other hand, the species of bacteria found in babies who were delivered by caesarean section (C-section) are more influenced by bacteria from the mother’s skin and the general environment. There is also more chance of unwanted opportunistic invaders colonizing the newborn, to occupy niches that would normally have been inhabited by commensals. Prevailing species in C-section neonates were Citrobacter spp., E. coli, and C. difficile. A notable deficit in bifidobacterial species was also detected. These organisms are known to be very beneficial to the human host. It was also found that Bacteroides spp., which usually colonize a newborn within 3–10 days from birth,Citation31 were still present in very low numbers, even 6 months into the life of the child, showing a significant delay in colonization. It has been suggested that this departure from normal gut microbiota composition and delayed colonization of beneficial commensals in babies, due to procedures such as C-sections, which need extra antiseptic measures for surgical interventions, as well as a general culture of sanitation and hygiene, has contributed to the allergy burden carried by many Western nations. Recent study pigeonholed a placental microbiome profile and found that nonpathogenic commensal microbiota from the Firmicutes, Tenericutes, Proteobacteria, Bacteroidetes, and Fusobacteria phyla.Citation166 Thereafter, it was reported that within the first week of life, the full-term neonatal gut microbiome is largely colonized by Actinobacteria, Proteobacteria, Bacteroidetes, and, much less, Firmicutes phyla.Citation165,Citation166 Oversterilizations of our environment, a lower incidence of disease, as well as changes to diet have resulted in lowered exposure to pathogens and antigens and have led to a change in the communities of friendly bacteria that live inside humans. This has possibly led to higher incidences of atopic conditions and leads to the concept of good dirt and that commensal bacteria in early life can defend against future occurrences of allergy.Citation167 Breast milk has been found to have significant prebiotic properties to the microbiome of infants.Citation168,Citation169 Oligosaccharides constitute the third highest concentration of all nutrients that make up breast milk. Mammalian enzymes are unable to digest oligosaccharides, which led to the thinking that these carbohydrates were there to satisfy the nutritional needs of commensal bacteria, rather the child itself.Citation170–Citation172 In an experiment, it was shown that the growth of two strains of bifidobacteria, B. longum ATCC 15697 and B. longum JCM 7007, was promoted when given human milk oligosaccharides (HMOs). Conversely, when HMOs were supplied to Clostridium perfringens, a pathogen that is one of the most common causes of food poisoning, an inhibitory effect was noted.Citation173 Finally, the maternal microbiota outlines the immune scheme of the progenies. Maternal colonization reprograms intestinal transcriptional silhouettes of the descendants, including amplified expression of genes encoding epithelial antibacterial peptides and metabolism of microbial molecules.Citation174
The elderly
The microbiome changes significantly as time passes and the age of the human host increases. There has been found to be greater differences in the gut communities of individuals aged >65 years, than that in younger adults.Citation175,Citation176 This may be attributed to a greater variation in diets of geriatrics dependent on their social situation and environment.Citation110,Citation177 An experiment was conducted – a test group of elderly subjects (mean age =78 years) was selected and classified into four groups, ranging from community-residing individuals to those in long-term residential care, two ends of a spectrum. A small number of young healthy adults (mean age =36 years) were also included in the study for comparison purposes.Citation177 Food diaries of dietary intake were kept by each individual, and an analysis of bacteria in their fecal material was conducted. It was found that community-dwelling subjects had the healthiest microbiomes, which were akin to those of the younger cohort of test subjects.Citation177 On the other hand, microbiomes of the long-term residential group were the most removed from those of a healthy adult, with a lower diversity of the species of bacteria present.Citation177 An analysis for SCFA production was also conducted, which showed that the bacteria of community subjects possessed more genes that coded for enzymes that produce SCFA than those of long-term residents.Citation177 When this data is compared with the diets of the subjects, it becomes more apparent from where this disparity stems.Citation177 Most community geriatric diets came under the category of high fiber/low fat, whereas long-term subjects fell under low fiber/high fat, with the biggest differences in food intake revolving around fruit, vegetables, and meat.Citation110,Citation177,Citation178 This shows that diverse and healthy diet results in a similarly positive microbiome and vice versa. Another study has shown that the gut bacteria composition of centenarians differs significantly from that of young or elderly humans.Citation179
Conclusion
A multiplicity of studies involving the gut microbiome has come to a convergent conclusion that commensal bacterium in the human body plays an undeniably important role in host physiological functions. They are involved in metabolizing foods, which allows the body to reclaim nutrients that would otherwise be lost as SCFAs such as butyrate. The microbiota has also been shown to provide protection from many chronic diseases of the gut, and they truly deserve the nickname of friendly bacteria.
Disclosure
The authors report no conflicts of interest in this work.
References
- LederbergJMcCrayAT webpage on the Internet‘Ome sweet’ omics—a genealogical treasury of wordsScientist2001158 Available from: http://www.the-scientist.com/?articles.view/articleNo/13313/title/-Ome-Sweet--Omics---A-Genealogical-Treasury-of-Words/Accessed September 19, 2016
- SinDSzeMHoggJBacterial microbiome of lungs in COPDInt J Chron Obstruct Pulmon Dis20149122923824591822
- GriceEASegreJAThe human microbiome: our second genomeAnnu Rev Genomics Hum Genet20121315117022703178
- GriceEASegreJAThe skin microbiomeNat Rev Microbiol20119424425321407241
- UrsellLKMetcalfJLParfreyLWKnightRDefining the human microbiomeNutr Rev201270Suppl 1S38S4422861806
- TurnbaughPJLeyREHamadyMFraser-LiggettCMKnightRGordonJIThe human microbiome projectNature200744980481017943116
- SavageDCMicrobial ecology of the gastrointestinal tractAnnu Rev Microbiol197731107133334036
- NIH HMP Working GroupPetersonJGargesSThe NIH Human Microbiome ProjectGenome Res200919122317232319819907
- DonohoeDRGargeNZhangXSunWThe microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colonCell Metab201113551752621531334
- BianconiEPiovesanAFacchinFAn estimation of the number of cells in the human bodyAnn Hum Biol201340646347123829164
- RosnerJLTen times more microbial cells than body cells in humans?Microbe20149247
- Institute of Medicine (US) Forum on Microbial ThreatsMicrobial Evolution and Co-Adaptation: A Tribute to the Life and Scientific Legacies of Joshua Lederberg: workshop summary [webpage on the Internet]Washington, DCNational Academies Press2009 Available from: http://www.ncbi.nlm.nih.gov/books/NBK45714/Accessed August 20, 2016
- CabralJPSWater microbiology. Bacterial pathogens and waterInt J Environ Res Public Health20107103657370321139855
- SaxenaGBharagavaRNKaithwasGRajAMicrobial indicators, pathogens and methods for their monitoring in water environmentJ Water Health201513231933926042966
- FarooquiAKhanAKazmiSUInvestigation of a community outbreak of typhoid fever associated with drinking waterBMC Public Health2009947620021691
- SartelliMWeberDGRuppéEWorld J Emerg Surg2016113327429642
- HaqueMRahmanNIAZulkifliZIsmailSAntibiotic prescribing and resistance: knowledge level of medical students of clinical years of University Sultan Zainal Abidin, MalaysiaTher Clin Risk Manag20161241342627042083
- HoqueRMostafaAHaqueMIntern doctors’ views on the current and future antibiotic resistance situation of Chattagram Maa O Shishu Hospital Medical College, BangladeshTher Clin Risk Manag2015111177118526316762
- HoqueRMostafaAHaqueMInsight of medical students of clinical years to antimicrobials prescribing and resistance in private medical school, Chittagong, BangladeshJ Young Pharm201684447455
- MillerGFischerDKBeneficial effects of human virusesYale J Biol Med198154157636264697
- BryceKFungi: Ecological Importance and Impact on HumansChichesterJohn Wiley & Sons Ltd2011
- RelmanDAFalkowSThe meaning and impact of the human genome sequence for microbiologyTrends Microbiol2001920620811336835
- RelmanDANew technologies, human–microbe interactions, and the search for previously unrecognized pathogensJ Infect Dis2002186S254S25812424706
- BaughRFBaughADInfection, causation and indigenous floraJ Aller Ther20123e104
- SekirovIFinlayBHuman and microbe: united we standNat Med200612773673716829917
- PhillipsMLGut reaction: environmental effects on the human micro-biotaEnviron Health Perspect20091175A198A20519478986
- Institute of Medicine (US) Food ForumThe Human Microbiome, Diet, and Health: workshop summary [webpage on the Internet]Washington (DC)National Academies Press2013 Available from: http://www.ncbi.nlm.nih.gov/books/NBK154093/Accessed September 21, 2016
- Institute of Medicine (US) Forum on Microbial ThreatsEnding the War Metaphor: The Changing Agenda for Unraveling the Host-Microbe Relationship: workshop summary [webpage on the Internet]Washington (DC)National Academies Press2006 Available from: http://www.ncbi.nlm.nih.gov/books/NBK57060/Accessed September 21, 2016
- Forum on Microbial HealthBoard on Global HealthInstitute of MedicineMicrobial Ecology in States of Health and Disease: workshop summary [webpage on the Internet]Washington (DC)National Academies Press2014 Available from: http://www.ncbi.nlm.nih.gov/books/NBK189983/Accessed September 21, 2016
- Institute of Medicine (US) Forum on Microbial ThreatsThe Social Biology of Microbial Communities: workshop summary [webpage on the Internet]Washington (DC)National Academies Press2012 Available from: http://www.ncbi.nlm.nih.gov/books/NBK154544/Accessed September 21, 2016
- WexlerHMBacteroides: the good, the bad, and the nitty-grittyClin Microbiol Rev200720459362117934076
- JiBNielsenJNew insight into the gut microbiome through metagenomicsAdv Genomics Genet201557791
- BakhtiarSMLeBlancJGSalvucciEImplications of the human microbiome in Inflammatory Bowel DiseasesFEMS Microbiol Lett20133421101723431991
- JandhyalaSMTalukdarRSubramanyamCVuyyuruHSasikalaMReddyDNRole of the normal gut microbiotaWorld J Gastroenterol201521298787880326269668
- BelkaidYHandTRole of the microbiota in immunity and inflammationCell2014157112114124679531
- LangdonACrookNDantasGThe effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulationGenome Med201683927074706
- GuinaneCMCotterPDRole of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organTherap Adv Gastroenterol201364295308
- EttingerGMacDonaldKReidGBurtonJPThe influence of the human microbiome and probiotics on cardiovascular healthGut Microbes20145671972825529048
- WingleeKFodorAAIntrinsic association between diet and the gut microbiome: current evidenceNutr Diet Suppl201576976
- DavisCPChapter 6: Normal flora [webpage on the Internet]BaronSMedical Microbiology4th edGalveston (TX)University of Texas Medical Branch at Galveston1996 Available from: https://www.ncbi.nlm.nih.gov/books/NBK7617/Accessed October 16, 2016
- MacfarlaneGTMacfarlaneSBacteria, colonic fermentation, and gastrointestinal healthJ AOAC Int2012951506022468341
- MacfarlaneSHopkinsMJMacfarlaneGTBacterial growth and metabolism on surfaces in the large intestineMicrob Ecol Health Dis200026472
- Gut microbiota for healthGut microbiota info [webpage on the Internet] Available from: http://www.gutmicrobiotaforhealth.com/en/about-gut-microbiota-info/Accessed February 27, 2017
- van der WaaijLAHarmsenHJMadjipourMBacterial population analysis of human colon and terminal ileum biopsies with 16S rRNA-based fluorescent probes: commensal bacteria live in suspension and have no direct contact with epithelial cellsInflamm Bowel Dis20051186587116189415
- MarchesiJRHuman distal gut microbiomeEnviron Microbiol201113123088310221906225
- MacfarlaneSMacfarlaneGTRegulation of short-chain fatty acid productionProc Nutr Soc200362677212740060
- Institute of MedicineDietary, functional, and total fiber dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids [webpage on the Internet]Washington, DCThe National Academic Press2005 Available from: https://fnic.nal.usda.gov/sites/fnic.nal.usda.gov/files/uploads/energy_full_report.pdfAccessed August 31, 2016
- CummingsJHShort chain fatty acids in the human colonGut19812297637797028579
- HijovaEChmelarovaAShort chain fatty acids and colonic healthBratisl Lek Listy2007108835435818203540
- CummingsJHMacfarlaneGTThe control and consequences of bacterial fermentation in the human colonJ Appl Bacteriol19917064434591938669
- KimJKunduMViolletBGuanKLAMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1Nat Cell Biol2001132132141
- TurnbaughPJRidauraVKFaithJJReyFEGordonJIThe effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic miceSci Transl Med200916119
- MorrisonDJPrestonTFormation of short chain fatty acids by the gut microbiota and their impact on human metabolismGut Microbes20167318920026963409
- ChangPVHaoLOffermannsSMedzhitovRThe microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibitionProc Natl Acad Sci U S A201411162247225224390544
- NastasiCCandelaMBonefeldCMThe effect of short-chain fatty acids on human monocyte-derived dendritic cellsSci Rep201551614826541096
- VerniaPFracassoPLCasaleVTopical butyrate for acute radiation proctitis: randomized, crossover trialLancet200035692371232123511072942
- VerniaPAnneseVBresciGTopical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicenter trialEur J Clin Invest200333324424812641543
- CoxMAJacksonJStantonMShort-chain fatty acids act as anti-inflammatory mediators by regulating prostaglandin E2 and cytokinesWorld J Gastroenterol200915445549555719938193
- DeshmaneSLKremlevSAminiSSawayaBEMonocyte chemoattractant protein-1 (MCP-1): an overviewJ Interferon Cytokine Res200929631332619441883
- BindelsLBPorporatoPDewulfEMGut microbiota-derived propionate reduces cancer cell proliferation in the liverBr J Cancer201210781337134422976799
- LuptonJRDiet induced changes in the colonic environment and colorectal cancer. Microbial degradation products influence colon cancer risk: the butyrate controversyJ Nutr2004134247948214747692
- Food Quality and Standards Service (AGNS) Food and Agriculture Organization of the United Nations (FAO). FAO Technical Meeting on Prebiotics [webpage on the Internet]2007 Available from: https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=2&cad=rja&uact=8&ved=0ahUKEwiu_4CohOvOAhWKqo8KHSjyCZEQFggtMAE&url=http%3A%2F%2Fwww.aat-taa.eu%2Findex%2Fen%2Fcompany%2Fdownload%2F1262610500.html&usg=AFQjCNHQcmt3Yr7aVimPbXm-lNpO-UNK8Q&sig2=EpOjN3rnHZ2JJKPkPO6uVQAccessed August 31, 2016
- PineiroMAspNGReidGJ Clin Gastroenterol200842Suppl 3; Pt 2S156S15918685504
- MacfarlaneSMacfarlaneGTCummingsJHReview article prebiotics in the gastrointestinal tractAliment Pharmacol Ther200624570171416918875
- MacfarlaneGTSteedHMacfarlaneSBacterial metabolism and health-related effects of galacto-oligosaccharides and other prebioticsJ Appl Microbiol2008104230534418215222
- FelisGEDellaglioFTaxonomy of lactobacilli and bifidobacteriaCurr Issues Intest Microbiol200782446117542335
- MacfarlaneGTMacfarlaneSManipulating the indigenous microbiota in humans- prebiotics, probiotics and symbioticsFredricksDNThe Human Microbiota: How Microbial Communities Affect Health and DiseaseHoboken, NJJohn Wiley & Sons Inc2013315334
- ManningTSGibsonGRPrebioticsBest Pract Res Clin Gastroenterol200418228729815123070
- VyasURanganathanNProbiotics, prebiotics, and symbiotics: gut and beyondGastroenterol Res Pract201212012116
- MartinezFBalciunasEConvertiACotterPDPinheiroRde Souza OliveiraRPBacteriocin production by Bifidobacterium spp. A reviewBiotechnol Adv201331448248823384878
- DiRienzoDEffect of probiotics on biomarkers of cardiovascular disease: implications for heart-healthy dietsNutr Rev2014721182924330093
- GilbertJKrajmalnik-BrownRPorazinskaDLWeissSJKnightRToward effective probiotics for autism and other neurodevelopmental disordersCell201315571446144824360269
- JonesMLMartoniCJPrakashSOral supplementation with probiotic L. reuteri NCIMB 30242 increases mean circulating 25-hydroxyvitamin D: a post hoc analysis of a randomized controlled trialJ Clin Endocrinol Metab20139872944295123609838
- BaekYJLeeBHProbiotics and prebiotics as bioactive components in dairy productsParkYWBioactive Components in Milk Dairy ProductsNew YorkWiley-Blackwell2009
- DaliriEBMLeeBHNew perspectives on probiotics in health and diseaseFood Sci Hum Wellness2015425665
- McAuliffeOCanoRJKlaenhammerTRGenetic analysis of two bile salt hydrolase activities in Lactobacillus acidophilus NCFMAppl Environ Microbiol20057184925492916085898
- IshimweNDaliriEBLeeBHFangFDuGThe perspective on cholesterol-lowering mechanisms of probioticsMol Nutr Food Res20155919410525403164
- OoiLGLiongMTCholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findingsInt J Mol Sci20101162499252220640165
- WaigankarSPatelVRole of probiotics in urogenital healthcareJ Midlife Health20112151021897732
- BanasJAPoppERecovery of viable bacteria from probiotic products that target oral healthProbiotics Antimicrob Proteins20135322723124015157
- LoescheWJRole of Streptococcus mutans in human dental decayMicrobiol Rev19865043533803540569
- AnilkumarKMonishaARole of friendly bacteria in oral health – a short reviewOral Health Prev Dent20121013822908082
- BizziniBPizzoGScapagniniGNuzzoDVastoSProbiotics and oral healthCurr Pharm Des201218345522553122632388
- HaukiojaAProbiotics and oral healthEur J Dent20104334835520613927
- Di PierroFAdamiTRapacioliGGiardiniNStreitbergerCClinical evaluation of the oral probiotic Streptococcus salivarius K12 in the prevention of recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes in adultsExpert Opin Biol Ther201313333934323286823
- Di PierroFColomboMZanvitARissoPRottoliAUse of Streptococcus salivarius K12 in the prevention of streptococcal and viral pharyngotonsillitis in childrenDrug Healthc Patient Saf20146152024600248
- IbrahimSAO’SullivanDJUse of chemical mutagenesis for the isolation of food grade β-galactosidase overproducing mutants of bifidobacteria, lactobacilli and Streptococcus thermophilusJ Dairy Sci200083592393010821566
- van den BogaardPTKleerebezemMKuipersOPde VosWMControl of lactose transport, β-galactosidase activity, and glycolysis by CcpA in Streptococcus thermophilus: evidence for carbon catabolite repression by a non-phosphoenolpyruvate-dependent phosphotransferase system sugarJ Bacteriol2000182215982598911029416
- GohYJKlaenhammerTRA functional glycogen biosynthesis pathway in Lactobacillus acidophilus: expression and analysis of the glgoperonMol Microbiol20138961187120023879596
- Foxx-OrensteinAECheyWDManipulation of the gut microbiota as a novel treatment strategy for gastrointestinal disordersAm J Gastroenterol201214146
- van ZantenGCKnudsenARöytiöHThe effect of selected symbiotics on microbial composition and short-chain fatty acid production in a model system of the human colonPLoS One2012710e4721223082149
- FurrieEMacfarlaneSKennedyASymbiotic therapy (Bifidobacteria longum/synergy 1) initiates resolution of inflammation in patients with active ulcerative colitisGut200554224224915647189
- MiquelSMartínRRossiOFaecalibacterium prausnitzii and human intestinal healthCurr Opin Microbiol201316325526123831042
- LiMWangBZhangMSymbiotic gut microbes modulate human metabolic phenotypesProc Natl Acad Sci U S A200810562117212218252821
- FoditschCPereiraRVGandaEKOral administration of Faecalibacterium prausnitzii decreased the incidence of severe diarrhea and related mortality rate and increased weight gain in preweaned dairy heifersPLoS One20151012e014548526710101
- RoundJLMazmanianSKThe gut microbiome shapes intestinal immune responses during health and diseaseNat Rev Immunol20099531332319343057
- IzcueAHueSBuonocoreSInterleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis. T cells can induce colitis in IL-23 deficient recipients, suggesting that disease can result in the absence of regulationImmunity200828455957018400195
- FallaniMYoungDScottJIntestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breast-feeding, and antibioticsJ Pediatr Gastroenterol Nutr2010511778420479681
- BrownKDeCoffeDMolcanEGibsonDLDiet-induced dysbiosis of the intestinal microbiota and the effects on immunity and diseaseNutrients2012481095111923016134
- CenitMCOlivaresMCodoñer-FranchPSanzYIntestinal microbiota and celiac disease: cause, consequence or co-evolution?Nutrients2015786900692326287240
- ColladoMCDonatERibes-KoninckxCCalabuigMSanzYSpecific duodenal and faecal bacterial groups associated with paediatric coeliac diseaseJ Clin Pathol20096226426918996905
- ColladoMCDonatERibes-KoninckxCCalabuigMSanzYImbalances in faecal and duodenal Bifidobacterium species composition in active and non-active coeliac diseaseBMC Microbiol2008823219102766
- Di CagnoRDe AngelisMDe PasqualeIDuodenal and faecal microbiota of celiac children: molecular, phenotype and metabolome characterizationBMC Microbiol20111121921970810
- NistalECamineroAVivasSDifferences in faecal bacteria populations and faecal bacteria metabolism in healthy adults and celiac disease patientsBiochimie2012941724172922542995
- SanzYEffects of a gluten-free diet on gut microbiota and immune function in healthy adult humansGut Microbes20101313513721327021
- PachecoARBarileDUnderwoodMAMillsDAThe impact of the milk glycobiome on the neonate gut microbiotaAnnu Rev Anim Biosci2015341944525387230
- ArrietaMCStiemsmaLTAmenyogbeNBrownEMFinlayBThe intestinal microbiome in early life: health and diseaseFront Immun20145427
- TaylorSNBasileLAEbelingMWagnerCLIntestinal permeability in preterm infants by feeding type: mother’s milk versus formulaBreastfeed Med200941111519196035
- SekirovIRussellSCaetanoLAntunesMFinlayBBGut microbiota in health and diseaseAm Physiol Soc201090859904
- ConlonMABirdARThe impact of diet and lifestyle on gut microbiota and human healthNutrients2015711744
- MylesIAFast food fever: reviewing the impacts of the Western diet on immunityNutr J2014136124939238
- WuGDChenJHoffmannCLinking long-term dietary patterns with gut microbial enterotypesScience2011334605210510821885731
- PendyalaSWalkerJMHoltPRA high-fat diet is associated with endotoxemia that originates from the gutGastroenterology201214251100110122326433
- DueñasMMuñoz-GonzálezICuevaCA survey of modulation of gut microbiota by dietary polyphenolsBiomed Res Int2015201585090225793210
- HullarMAJFuBCDiet, the gut microbiome, and epigeneticsCancer J201420317017524855003
- De FilippoCCavalieriDDi PaolaMImpact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural AfricaProc Natl Acad Sci USA201010733146911469620679230
- YatsunenkoTReyFEManaryMJHuman gut microbiome viewed across age and geographyNature2012486740222222722699611
- LinABikEMCostelloEKDistinct distal gut microbiome diversity and composition in healthy children from Bangladesh and the United StatesPLoS One201381e5383823349750
- LaparraJMSanzYInteractions of gut microbiota with functional food components and nutraceuticalsPharmacol Res201061321922519914380
- HeXMarcoMLSlupskyCMEmerging aspects of food and nutrition on gut microbiotaJ Agric Food Chem201361409559957424028159
- Hervert-HernandezDGoñiIDietary polyphenols and human gut microbiota: a reviewFood Rev Int2011272154169
- TuohyKMConternoLGasperottiMViolaRUpregulating the human intestinal microbiome using whole plant foods, polyphenols, and/or fiberJ Agric Food Chem201260368776878222607578
- EtxeberriaUFernández-QuintelaAMilagroFIAguirreLMartínezJAPortilloMPImpact of polyphenols and polyphenol-rich dietary sources on gut microbiota compositionJ Agric Food Chem201361409517953324033291
- CardonaFAndrés-LacuevaCTulipaniSTinahonesFJQueipo-OrtuñoMIBenefits of polyphenols on gut microbiota and implications in human healthJ Nutr Biochem20132481415142223849454
- SelmaMVEspínJCTomás-BarberánFAInteraction between phenolics and gut microbiota: role in human healthJ Agric Food Chem200957156485650119580283
- Johns Hopkins MedicineGastroenterology and Hepatology. Fecal Transplantation (Bacteriotherapy) Available from: http://www.hop-kinsmedicine.org/gastroenterology_hepatology/clinical_services/advanced_endoscopy/fecal_transplantation.htmlAccessed February 27, 2017
- BakkenJSBorodyTBrandtLJTreating Clostridium difficile infection with fecal microbiota transplantationClin Gastroenterol Hepatol20119121044104921871249
- KassamZLeeCHYuanYHuntRHFecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysisAm J Gastroenterol2013108450050823511459
- BorodyTJKhorutsAFecal microbiota transplantation and emerging applicationsNat Rev Gastroenterol Hepatol201192889622183182
- LooVGPoirierLMillerMAA predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortalityN Engl J Med2005353232442244916322602
- VonbergRPReichardtCBehnkeMSchwabFZindlerSGastmeierPCost of nosocomial Clostridium difficile-associated diarrheaJ Hosp Infect20087011520
- DubberkeEROlsenMABurden of Clostridium difficile on the healthcare systemClin Infect Dis201255Suppl 2S88S9222752870
- KhorBGardetAXavierRGenetics and pathogenesis of inflammatory bowel diseaseNature2011474735130731721677747
- EkWED’AmatoMHalfvarsonJThe history of genetics in inflammatory bowel diseaseAnn Gastroenterol201427429430325331623
- EconomouMPappasGNew global map of Crohn’s disease: genetic, environmental, and socioeconomic correlationsInflamm Bowel Dis200814570972018095316
- SwansonGRBurgessHJKeshavarzianASleep disturbances and inflammatory bowel disease: a potential trigger for disease flare?Expert Rev Clin Immunol201171293621162647
- AliTChoeJAwabAWagenerTLOrrWCSleep, immunity and inflammation in gastrointestinal disordersWorld J Gastroenterol201319489231923924409051
- KinnucanJARubinDTAliTSleep and inflammatory bowel disease: exploring the relationship between sleep disturbances and inflammationGastroenterol Hepatol2013911718727
- GamaldoCEShaikhAKMcArthurJCThe sleep-immunity relationshipNeurol Clin20123041313134323099140
- SookoianSGemmaCFernández GianottiTEffects of rotating shift work on biomarkers of metabolic syndrome and inflammationJ Intern Med2007261328529217305651
- RanjbaranZKeeferLStepanskiEFarhadiAKeshavarzianAThe relevance of sleep abnormalities to chronic inflammatory conditionsInflamm Res2007562515717431741
- Van CauterESpiegelKTasaliELeproultRMetabolic consequences of sleep and sleep lossSleep Med20089Suppl 1S23S2818929315
- DaneseSSansMFiocchiCInflammatory bowel disease: the role of environmental factorsAutoimmun Rev20043539440015288007
- MolodeckyNAKaplanGGEnvironmental risk factors for inflammatory bowel diseaseGastroenterol Hepatol201065339346
- MatsuokaKKanaiTThe gut microbiota and inflammatory bowel diseaseSemin Immunopathol201537475525420450
- DeGruttolaAKLowDMizoguchiACurrent understanding of dysbiosis in disease in human and animal modelsInflamm Bowel Dis2016221137115027070911
- MorganXCTickleTLSokolHDysfunction of the intestinal microbiome in inflammatory bowel disease and treatmentGenome Biol2012139R7923013615
- DamANBergAMFarrayeFAEnvironmental influences on the onset and clinical course of Crohn’s disease—Part 1: an overview of external risk factorsGastroenterol Hepatol2013911711717
- MahidSSMinorKSSotoREHornungCAGalandiukSSmoking and inflammatory bowel disease: a meta-analysisMayo Clin Proc2006811462147117120402
- HiguchiLMKhaliliHChanATRichterJMBousvarosAFuchsCSA prospective study of cigarette smoking and the risk of inflammatory bowel disease in womenAm J Gastroenterol20121071399140622777340
- MacfarlaneSBahramiBMacfarlaneGTMucosal biofilm communities in the human intestinal tractAdv Appl Microbiol20117511114321807247
- MacfarlaneSSteedHMacfarlaneGTIntestinal bacteria and inflammatory bowel diseaseCrit Rev Clin Lab Sci2009461255419107650
- SteedHMacfarlaneGTBlackettKLClinical trial: the microbiological and immunological effects of symbiotic consumption – a randomized double-blind placebo-controlled study in active Crohn’s diseaseAliment Pharmacol Ther201032787288320735782
- Crohn’s and Colitis UKUlcerative Colitis [webpage on the Internet]2016 Available from: http://s3-eu-west-1.amazonaws.com/files.crohnsandcolitis.org.uk/Publications/ulcerative-colitis.pdfAccessed August 31, 2016
- MieleEPascarellaFGiannettiEQuagliettaLBaldassanoRNEffect of a probiotic preparation (VSL # 3) on induction and maintenance of remission in children with ulcerative colitisAm J Gastroenterol2009104243744319174792
- NHSPrescQIPP. Review of probiotic treatment, including VSL#3® for ileoanal-pouchitis (DROP-List)Bulletin 822014 Available from: http://pad.res360.net/Content/Documents/PresQIPP-bulletin-82-probiotics.pdfAccessed February 27, 2017
- SelingerCPBellACairnsALockettMSebastianSHaslamNProbiotic VSL# 3 prevents antibiotic-associated diarrhea in a double-blind, randomized, placebo-controlled clinical trialJ Hosp Infect201384215916523618760
- AndrewsJMTanMProbiotics in luminal gastroenterology: the current state of playIntern Med J201242121287129123252997
- National Institute for Health and Clinical Excellence (NICE)Irritable bowel syndrome in adults: diagnosis and management [webpage on the Internet]2015 Available from: https://www.nice.org.uk/Guidance/cg61Accessed August 31, 2016
- VahediHAnsariRMir-NasseriMMJafariEIrritable bowel syndrome: a review articleMiddle East J Dig Dis201022667725197516
- MaddenJAJHunterJOA review of the role of the gut microflora in irritable bowel syndrome and the effects of probioticsBri J Nutr200288Suppl 16772
- GritzECBhandariVThe human neonatal gut microbiome: a brief reviewFrontiers in Pediatr2015317
- GrönlundMMLehtonenOPEerolaEKeroPFecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean deliveryJ Pediat Gastroenterol Nutr19992811925
- PandeyPKVermaPKumarHBavdekarAPatoleMSShoucheYSComparative analysis of fecal microflora of healthy full-term Indian infants born with different methods of delivery (vaginal vs cesarean): Acinetobacter sp. prevalence in vaginally born infantsJ Biosci201237698999823151789
- AagaardKMaJAntonyKMGanuRPetrosinoJVersalovicJThe placenta harbors a unique microbiomeSci Transl Med20146237237ra65
- AdlerberthIWoldAEEstablishment of the gut microbiota in Western infantsActa Paediatr20099822923819143664
- OkadaHKuhnCFeilletHBachJThe “hygiene hypothesis” for autoimmune and allergic diseases: an updateClin Exp Immunol2010160119
- HoughtelingPDWalkerWAWhy is initial bacterial colonization of the intestine important to the infant’s and child’s health?J Pediatr Gastroenterol Nutr201560329430725313849
- GuaraldiFSalvatoriGEffect of breast and formula feeding on gut microbiota shaping in newbornsFront Cell Infect Microbiol201229423087909
- MarcobalA1BarbozaMFroehlichJWConsumption of human milk oligosaccharides by gut-related microbesJ Agric Food Chem20105895334534020394371
- BallardOMorrowALHuman milk composition: nutrients and bioactive factorsPediatr Clin North Am2013601497423178060
- WangBBrand-MillerJThe role and potential of sialic acid in human nutritionEur J Clin Nutr200357111351136914576748
- YuZTChenCKlingDEThe principal fucosylated oligosaccharides of human milk exhibit prebiotic properties on cultured infant microbiotaGlycobiology201323216917723028202
- Gomez de AgüeroMGanal-VonarburgSCFuhrerTThe maternal microbiota drives early postnatal innate immune developmentScience201635162791296130226989247
- BiagiECandelaMFairweather-TaitSFranceschiCBrigidiPAgeing of the human metaorganism: the microbial counterpartAge201234124726721347607
- OdamakiTKatoKSugaharaHAge-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional studyBMC Microbiol2016169027220822
- ClaessonMJJefferyIBCondeSGut microbiota composition correlates with diet and health in the elderlyNature2012488741017818422797518
- HughesVMicrobiome: cultural differencesNature20124927427S14S1523222668
- BiagiENylundLCandelaMThrough ageing, and beyond: gut microbiota and inflammatory status in seniors and centenariansPLoS One201055e1066720498852